Cargando…
Combined treatment of non‐small cell lung cancer using radiotherapy and immunotherapy: challenges and updates
The efficacy of immunotherapy for advanced non‐small cell lung cancer (NSCLC) remains unsatisfactory, as the majority of patients either do not experience an objective response or acquire secondary resistance. As a result, several methods to enhance the systemic efficacy of immunotherapy have been i...
Autores principales: | Shang, Shijie, Liu, Jie, Verma, Vivek, Wu, Meng, Welsh, James, Yu, Jinming, Chen, Dawei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626591/ https://www.ncbi.nlm.nih.gov/pubmed/34658186 http://dx.doi.org/10.1002/cac2.12226 |
Ejemplares similares
-
New challenges in the combination of radiotherapy and immunotherapy in non-small cell lung cancer
por: Luna, Javier, et al.
Publicado: (2021) -
Radiotherapy combined with immunotherapy: the dawn of cancer treatment
por: Zhang, Zengfu, et al.
Publicado: (2022) -
Patients with Lower Positive Lymph Nodes Ratio May Benefit from
Preoperative Radiotherapy in Stage III Non-Small Cell Lung
Cancer
por: Wang, Ruiyang, et al.
Publicado: (2023) -
Pivotal roles of tumor‐draining lymph nodes in the abscopal effects from combined immunotherapy and radiotherapy
por: Liu, Zhaoyun, et al.
Publicado: (2022) -
Crossed Pathways for Radiation-Induced and Immunotherapy-Related Lung Injury
por: Zhang, Zengfu, et al.
Publicado: (2021)